Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-303849
Filing Date
2025-12-01
Accepted
2025-12-01 16:02:23
Documents
1
Period of Report
2025-11-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5237
  Complete submission text file 0001193125-25-303849.txt   6848
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DVORA HANEVI'A ST 124 TEL AVIV Israel 6944020
Business Address
MIGNONE ROBERTO (Reporting) CIK: 0001258394 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 251539557